AAAAAA
Results:
1-22
|
Results: 22
Authors:
BRUNING PF
BONFRER JMG
PARIDAENS R
NOOIJ M
KLIJN JGM
BEEX LVAM
BRUYNSEELS J
PICCART MJ
Citation: Pf. Bruning et al., VOROZOLE (R83842) IN THE TREATMENT OF POSTMENOPAUSAL ADVANCED BREAST-CANCER - RELATIONSHIP OF SERUM LEVELS OF VOROZOLE AND CLINICAL-RESULTS(A STUDY OF THE EORTC BREAST-CANCER COOPERATIVE GROUP), Anti-cancer drugs, 9(5), 1998, pp. 419-425
Authors:
BONFRER JMG
KORSE CM
NIEWEG OE
RANKIN EM
Citation: Jmg. Bonfrer et al., THE LUMINESCENCE IMMUNOASSAY S-100 - A SENSITIVE TEST TO MEASURE CIRCULATING S-100B - ITS PROGNOSTIC VALUE IN MALIGNANT-MELANOMA, British Journal of Cancer, 77(12), 1998, pp. 2210-2214
Authors:
VROUENRAETS BC
KROON BBR
KLAASE JM
BONFRER JMG
NIEWEG OE
VANSLOOTEN GW
VANDONGEN JA
Citation: Bc. Vrouenraets et al., VALUE OF LABORATORY TESTS IN MONITORING ACUTE REGIONAL TOXICITY AFTERISOLATED LIMB PERFUSION, Annals of surgical oncology, 4(1), 1997, pp. 88-94
Authors:
BONFRER JMG
LINDERS C
HAGEMAN PC
HILKENS JGW
KORSE CM
MOLTHOFF CFM
Citation: Jmg. Bonfrer et al., EFFECT OF PACLITAXEL (TAXOL(R)) ON CA-125 EXPRESSION AND RELEASE BY OVARIAN-CANCER CELL-LINES, Tumor biology, 18(4), 1997, pp. 232-240
Authors:
GAARENSTROOM KN
BONFRER JMG
KORSE CM
KENTER GG
KENEMANS P
Citation: Kn. Gaarenstroom et al., VALUE OF CYFRA-21-1, TPA, AND SCC-AG IN PREDICTING EXTRACERVICAL DISEASE AND PROGNOSIS IN CERVICAL-CANCER, Anticancer research, 17(4B), 1997, pp. 2955-2958
Authors:
BONFRER JMG
SCHOUWINK JH
KORSE CM
BAAS P
Citation: Jmg. Bonfrer et al., CYFRA-21-1 AND TPA AS MARKERS IN MALIGNANT MESOTHELIOMA, Anticancer research, 17(4B), 1997, pp. 2971-2973
Authors:
BONFRER JMG
KORSE CM
ISRAELS SP
Citation: Jmg. Bonfrer et al., SERUM S-100 HAS PROGNOSTIC-SIGNIFICANCE IN MALIGNANT-MELANOMA, Anticancer research, 17(4B), 1997, pp. 2975-2977
Authors:
BONFRER JMG
GAARENSTROOM KN
KORSE CM
VANBUNNINGEN BNFM
KENEMANS P
Citation: Jmg. Bonfrer et al., CYFRA-21-1 IN MONITORING CERVICAL-CANCER - A COMPARISON WITH TISSUE POLYPEPTIDE ANTIGEN AND SQUAMOUS-CELL-CARCINOMA ANTIGEN, Anticancer research, 17(3C), 1997, pp. 2329-2334
Authors:
BONFRER JMG
KORSE CM
VERSTRAETEN RA
VANKAMP GJ
HART GAM
KENEMANS P
Citation: Jmg. Bonfrer et al., CLINICAL-EVALUATION OF THE BYK LIA-MAT CA125-II ASSAY - DISCUSSION OFA REFERENCE VALUE, Clinical chemistry, 43(3), 1997, pp. 491-497
Authors:
ZELENIUCHJACQUOTTE A
BRUNING PF
BONFRER JMG
KOENIG KL
SHORE RE
KIM MY
PASTERNACK BS
TONIOLO P
Citation: A. Zeleniuchjacquotte et al., RELATION OF SERUM LEVELS OF TESTOSTERONE AND DEHYDROEPIANDROSTERONE-SULFATE TO RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN, American journal of epidemiology, 145(11), 1997, pp. 1030-1038
Authors:
DAVELAAR EM
BONFRER JMG
VERSTRAETEN RA
HUININK WWT
KENEMANS P
Citation: Em. Davelaar et al., CA 125 - A VALID MARKER IN OVARIAN-CARCINOMA PATIENTS TREATED WITH PACLITAXEL, Cancer, 78(1), 1996, pp. 118-127
Authors:
BAAS P
KORSE CM
BONFRER JMG
Citation: P. Baas et al., CYFRA-21.1 - A POTENTIAL MARKER IN MESOTHELIOMA, European journal of cancer, 31A, 1995, pp. 1262-1262
Authors:
BRUNING PF
VANDOORN J
BONFRER JMG
VANNOORD PAH
KORSE CM
LINDERS TC
HART AAM
Citation: Pf. Bruning et al., INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEIN-3 IS DECREASED IN EARLY-STAGE OPERABLE PREMENOPAUSAL BREAST-CANCER, International journal of cancer, 62(3), 1995, pp. 266-270
Authors:
GAARENSTROOM KN
BONFRER JMG
KENTER GG
KORSE CM
HART AAM
TRIMBOS JB
HELMERHORST TJM
Citation: Kn. Gaarenstroom et al., CLINICAL-VALUE OF PRETREATMENT SERUM CYFRA-21-1, TISSUE POLYPEPTIDE ANTIGEN, AND SQUAMOUS-CELL CARCINOMA ANTIGEN LEVELS IN PATIENTS WITH CERVICAL-CANCER, Cancer, 76(5), 1995, pp. 807-813
Authors:
BONFRER JMG
GROENEVELD EM
KORSE CM
VANDALEN A
OOMEN LCJM
IVANYI D
Citation: Jmg. Bonfrer et al., MONOCLONAL ANTIBODY-M3 USED IN TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN-ASSAY FOR THE QUANTIFICATION OF TISSUE POLYPEPTIDE ANTIGEN RECOGNIZES KERATIN-18, Tumor biology, 15(4), 1994, pp. 210-222
Authors:
BONFRER JMG
GROENEVELD EM
KORSE CM
VANDALEN A
OOMEN LCJM
IVANYI D
Citation: Jmg. Bonfrer et al., MONOCLONAL ANTIBODY-M3 USED IN TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN-ASSAY FOR THE QUANTIFICATION OF TISSUE POLYPEPTIDE ANTIGEN RECOGNIZES KERATIN-18, Tumor biology, 15(4), 1994, pp. 210-222
Authors:
BONFRER JMG
BAAN AW
JANSEN E
LENTFER D
KENEMANS P
Citation: Jmg. Bonfrer et al., TECHNICAL EVALUATION OF 3 2ND-GENERATION CA-125 ASSAYS, European journal of clinical chemistry and clinical biochemistry, 32(3), 1994, pp. 201-207
Authors:
BONFRER JMG
GAARENSTROOM KN
KENTER GG
KORSE CM
HART AAM
GALLEE MPW
HELMERHORST TJM
KENEMANS P
Citation: Jmg. Bonfrer et al., PROGNOSTIC-SIGNIFICANCE OF SERUM FRAGMENTS OF CYTOKERATIN-19 MEASUREDBY CYFRA-21-1 IN CERVICAL-CANCER, Gynecologic oncology, 55(3), 1994, pp. 371-375
Authors:
GAARENSTROOM KN
KENTER GG
BONFRER JMG
KORSE CM
GALLEE MPW
HART AAM
MULLER M
TRIMBOS JB
HELMERHORST TJM
Citation: Kn. Gaarenstroom et al., PROGNOSTIC-SIGNIFICANCE OF SERUM ANTIBODIES TO HUMAN PAPILLOMAVIRUS-16 E4 AND E7 PEPTIDES IN CERVICAL-CANCER, Cancer, 74(8), 1994, pp. 2307-2313
Authors:
KOENIG KL
TONIOLO P
BRUNING PF
BONFRER JMG
SHORE RE
PASTERNACK BS
Citation: Kl. Koenig et al., RELIABILITY OF SERUM PROLACTIN MEASUREMENTS IN WOMEN, Cancer epidemiology, biomarkers & prevention, 2(5), 1993, pp. 411-414
Authors:
VANOERS MHJ
PALS ST
EVERS LM
VANDERSCHOOT CE
KOOPMAN G
BONFRER JMG
HINTZEN RQ
VONDEMBORNE AEGK
VANLIER RAW
Citation: Mhj. Vanoers et al., EXPRESSION AND RELEASE OF CD27 IN HUMAN B-CELL MALIGNANCIES, Blood, 82(11), 1993, pp. 3430-3436
Authors:
BRUNING PF
BONFRER JMG
HART AAM
VANNOORD PAH
Citation: Pf. Bruning et al., WESTERN LIFE-STYLE AND BREAST-CANCER RISK, Acta Clinica Belgica, 48, 1993, pp. 2-5
Risultati:
1-22
|